 CAMBRIDGE, Mass., May 19, 2022 GLOBE NEWSWIRE -- Pyxis Oncology, Inc. Nasdaq: PYXS, a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, and members of the management team will present at the following upcoming investor conferences: 